HRD and other targetable mutations in ovarian cancer: The importance of tumor site of origin and cell type

Journal article

Peer reviewed

Chinmayi Aryasomayajula, Caitlin Johnson, Martins Ayoola, Chelsea Stewart, Bezhan Wahidi, Daniel Kapp, Ritu Salani, Dana Chase and John Chan

Gynecologic oncology, Vol.190, pp.S146-S146

11/2024

Metrics

1 Record Views

Title: HRD and other targetable mutations in ovarian cancer: The importance of tumor site of origin and cell type
Creators: Chinmayi Aryasomayajula - Kaiser Permanente
Caitlin Johnson - California Pacific Medical Center Research Institute, San Francisco, CA, United States
Martins Ayoola - University of California, Los Angeles
Chelsea Stewart - University of California, Los Angeles
Bezhan Wahidi - Sutter Health
Daniel Kapp - Stanford University
Ritu Salani - University of California, Los Angeles
Dana Chase - University of California, Los Angeles
John Chan - California Pacific Medical Center Research Institute, San Francisco, CA, United States
Publication Details: Gynecologic oncology, Vol.190, pp.S146-S146
Publisher: Elsevier Inc
Identifiers: 991006118332502656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article